IBDEI2QE ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43552,1,3,0)
 ;;=3^Hemiplegia Affecting Lt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,43552,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,43552,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,43553,0)
 ;;=I69.941^^160^2124^39
 ;;^UTILITY(U,$J,358.3,43553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43553,1,3,0)
 ;;=3^Monoplegia of Lower Limb Affecting Rt Dominant Side
 ;;^UTILITY(U,$J,358.3,43553,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,43553,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,43554,0)
 ;;=I69.942^^160^2124^37
 ;;^UTILITY(U,$J,358.3,43554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43554,1,3,0)
 ;;=3^Monoplegia of Lower Limb Affecting Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,43554,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,43554,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,43555,0)
 ;;=I69.943^^160^2124^40
 ;;^UTILITY(U,$J,358.3,43555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43555,1,3,0)
 ;;=3^Monoplegia of Lower Limb Affecting Rt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,43555,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,43555,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,43556,0)
 ;;=I69.944^^160^2124^38
 ;;^UTILITY(U,$J,358.3,43556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43556,1,3,0)
 ;;=3^Monoplegia of Lower Limb Affecting Lt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,43556,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,43556,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,43557,0)
 ;;=I69.928^^160^2124^47
 ;;^UTILITY(U,$J,358.3,43557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43557,1,3,0)
 ;;=3^Speech/Lang Deficits s/p Unspec Cerebrov Dis
 ;;^UTILITY(U,$J,358.3,43557,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,43557,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,43558,0)
 ;;=I69.961^^160^2124^43
 ;;^UTILITY(U,$J,358.3,43558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43558,1,3,0)
 ;;=3^Paralytic Syndrome Affecting Rt Dominant Side
 ;;^UTILITY(U,$J,358.3,43558,1,4,0)
 ;;=4^I69.961
 ;;^UTILITY(U,$J,358.3,43558,2)
 ;;=^5007564
 ;;^UTILITY(U,$J,358.3,43559,0)
 ;;=I69.962^^160^2124^41
 ;;^UTILITY(U,$J,358.3,43559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43559,1,3,0)
 ;;=3^Paralytic Syndrome Affecting Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,43559,1,4,0)
 ;;=4^I69.962
 ;;^UTILITY(U,$J,358.3,43559,2)
 ;;=^5133588
 ;;^UTILITY(U,$J,358.3,43560,0)
 ;;=I69.963^^160^2124^44
 ;;^UTILITY(U,$J,358.3,43560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43560,1,3,0)
 ;;=3^Paralytic Syndrome Affecting Rt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,43560,1,4,0)
 ;;=4^I69.963
 ;;^UTILITY(U,$J,358.3,43560,2)
 ;;=^5007565
 ;;^UTILITY(U,$J,358.3,43561,0)
 ;;=I69.964^^160^2124^42
 ;;^UTILITY(U,$J,358.3,43561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43561,1,3,0)
 ;;=3^Paralytic Syndrome Affecting Lt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,43561,1,4,0)
 ;;=4^I69.964
 ;;^UTILITY(U,$J,358.3,43561,2)
 ;;=^5133589
 ;;^UTILITY(U,$J,358.3,43562,0)
 ;;=I69.965^^160^2124^45
 ;;^UTILITY(U,$J,358.3,43562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43562,1,3,0)
 ;;=3^Paralytic Syndrome,Bilateral
 ;;^UTILITY(U,$J,358.3,43562,1,4,0)
 ;;=4^I69.965
 ;;^UTILITY(U,$J,358.3,43562,2)
 ;;=^5007566
 ;;^UTILITY(U,$J,358.3,43563,0)
 ;;=I69.90^^160^2124^51
 ;;^UTILITY(U,$J,358.3,43563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43563,1,3,0)
 ;;=3^Unspec Sequelae of Unspec Cerebrov Dis
 ;;^UTILITY(U,$J,358.3,43563,1,4,0)
 ;;=4^I69.90
